| Aetna | Reslizumab (Cinqair) | 2025-12-22 |
| Medicare NGS | Billing and Coding: Arthroscopic Lavage and Arthroscopic Debridement for the Osteoarthritic Knee – Medical Policy Article (52369) | 2025-12-22 |
| Medicare NGS | Billing and Coding: Bevacizumab and biosimilars (52370) | 2025-12-22 |
| Medicare NGS | Billing and Coding: Hyaluronans Intra-articular Injections of (52420) | 2025-12-22 |
| Medicare NGS | Billing and Coding: Cardiac Catheterization and Coronary Angiography (52850) | 2025-12-22 |
| Medicare NGS | Billing and Coding: Pain Management - injection of tendon sheaths, ligaments, ganglion cysts, carpal and tarsal tunnels (52863) | 2025-12-22 |
| Medicare NGS | Self-Administered Drug Exclusion List: Medical Policy Article (53021) | 2025-12-22 |
| Medicare NGS | Billing and Coding: Removal of Benign Skin Lesions (54602) | 2025-12-22 |
| Medicare NGS | Billing and Coding: Cardiovascular Nuclear Medicine (56743) | 2025-12-22 |
| Medicare NGS | Billing and Coding: Heavy Metal Testing (56767) | 2025-12-22 |